Trial intelligence / Profile preview

Ivabradine in children with dilated cardiomyopathy and acute heart failure

NCT04405804Phase 2Unknown

Start
Jun 2020
Primary completion
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ivabradine in dilated cardiomyopathy (DCM), Acute Heart Failure (AHF). Status: unknown.

02

Drugs

ivabradine
03

Conditions

dilated cardiomyopathy (DCM)Acute Heart Failure (AHF)

Beyond the preview

Go deeper on NCT04405804.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04405804.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call